Skip to main content
. 2022 Feb 2;14(3):778. doi: 10.3390/cancers14030778

Figure 1.

Figure 1

Design of an antibody–drug conjugate and recommended biological properties. Characteristic of antigen, antibody, linker–antibody attachment, linker, linker–payload attachment and payload are detailed. The antibody Fc part is implied in half-life and immunogenicity. The Fab part controls affinity and avidity to the targeted antigen.